Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 206–207 (2007)Cite this article

boxed-textde Nijs RN et al. (2006) Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med 355: 675–684

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sambrook P et al. (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328: 1747–1752

    Article  CAS  Google Scholar 

  2. Reginster JY et al. (1999) Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 9: 75–81

    Article  CAS  Google Scholar 

  3. Sambrook PN et al. (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner Res 18: 919–924

    Article  CAS  Google Scholar 

  4. Ringe JD et al. (2003) Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporos Int 14: 801–807

    Article  CAS  Google Scholar 

  5. Angeli A et al. (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39: 253–259

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Institute of Bone and Joint Research, Building 36, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales 2065, Australia sambrook@med.usyd.edu.au

Authors and Affiliations

  1. Philip N Sambrook PN Sambrook is a Professor of Rheumatology at the Kolling Institute, University of Sydney, Sydney, Australia.,

    Philip N Sambrook

Authors
  1. Philip N Sambrook
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sambrook, P. Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?. Nat Rev Endocrinol 3, 206–207 (2007). https://doi.org/10.1038/ncpendmet0417

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0417

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing